DF
GILD icon

DecisionPoint Financial’s Gilead Sciences GILD Stock Holding History

DecisionPoint Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.41K Sell
46
-13
-22% -$1.82K ﹤0.01% 206
2025
Q4 		$7.24K Buy
59
+13
+28% +$1.58K ﹤0.01% 221
2025
Q3 		$5.11K Hold
46
– – ﹤0.01% 171
2025
Q2 		$5.14K Buy
+46
New +$4.9K ﹤0.01% 176

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

DecisionPoint Financial's GILD Position: Q1 2026 in Review

DecisionPoint Financial reduced its Gilead Sciences (GILD) stake by 22% in Q1 2026, selling an estimated $1.82K and leaving 46 shares worth $6.41K. The position accounts for ﹤0.01% of the portfolio, ranked #206.

DecisionPoint Financial first reported a position in GILD in Q2 2025 and has held it in 4 quarters since. The position peaked at $7.24K in Q4 2025. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • DecisionPoint Financial held 46 shares of Gilead Sciences worth $6.41K as of Q1 2026.
  • DecisionPoint Financial sold 13 Gilead Sciences shares in Q1 2026, an estimated $1.82K.
  • Gilead Sciences made up ﹤0.01% of DecisionPoint Financial's portfolio in Q1 2026, its #206 holding.
  • DecisionPoint Financial first reported a position in Gilead Sciences in Q2 2025 and has held it in 4 quarters since.
  • DecisionPoint Financial's Gilead Sciences position peaked at $7.24K in Q4 2025.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on DecisionPoint Financial's 13F filing for Q1 2026, filed 6 May 2026.